4-(4-Bromo-2-fluorophenylsulfonyl)piperazine-1-carboxylic acid tert-butyl ester

Catalog No. :
ACPYTZ076
CAS No. :
937014-34-1
Molecular Formula :
C15H20BrFN2O4S
Molecular Weight :
423.30

IUPAC Name:tert-butyl 4-((4-bromo-2-fluorophenyl)sulfonyl)piperazine-1-carboxylate

4-(4-Bromo-2-fluorophenylsulfonyl)piperazine-1-carboxylic acid tert-butyl ester structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$326.00Login to see priceInquiryInquiry
250mg97%$654.00Login to see priceInquiryInquiry
1g97%$1307.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Bromo-2-fluorophenylsulfonyl)piperazine-1-carboxylic acid tert-butyl ester
IUPAC Nametert-butyl 4-((4-bromo-2-fluorophenyl)sulfonyl)piperazine-1-carboxylate
Molecular FormulaC15H20BrFN2O4S
Molecular Weight423.30
SMILESCC(C)(C)OC(=O)N1CCN(S(=O)(=O)C2=CC=C(Br)C=C2F)CC1
InChI KeyKJIIGGDRZPNWLW-UHFFFAOYSA-N
Synonym4-(4-Bromo-2-fluorophenylsulfonyl)piperazine-1-carboxylic acid tert-butyl ester;1-Piperazinecarboxylic acid, 4-[(4-bromo-2-fluorophenyl)sulfonyl]-, 1,1-dimethylethyl ester
CAS No.937014-34-1

Synthetic Route by SureRoute

1. ACPYTZ076 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPYTZ076 route product structure diagram
    ACPYTZ076937014-34-1
Inquiry

2. ACPYTZ076 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACPYTZ076 route product structure diagram
    ACPYTZ076937014-34-1
Inquiry

Comments (0)